An action spectrum of the riboflavin-photosensitized inactivation of lambda phage

Photochemistry and Photobiology

Volumn 81, Issue 2, 2005, Pages 474-480

  Martin, Christopher B ^a,c   Wilfong, Erin ^a   Ruane, Patrick ^b   Goodrich, Raymond ^b   Platz, Matthew ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Navigant Biotechnologies   (United States)

^c LAMAR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN;

ARTICLE; BACTERIOPHAGE LAMBDA; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; LASER; RADIATION EXPOSURE; RADIATION RESPONSE; SPECTROFLUOROMETRY; ULTRAVIOLET RADIATION;

BACTERIOPHAGE LAMBDA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; LASERS; MOLECULAR STRUCTURE; RIBOFLAVIN; SPECTROMETRY, FLUORESCENCE; ULTRAVIOLET RAYS;

BACTERIOPHAGE LAMBDA;

EID: 17444361884     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2004-08-25-RA-292.1     Document Type: Article

References (28)

1. Busch, M. P., S. H. Kleinman and G. J. Nemo (2003) Current and emerging infectious risks of blood transfusions. J. Am. Med. Assoc. 289, 959-962.
2. Cummings, P. D., E. L. Wallace, J. B. Schoir and R. Y. Dodd (1989) Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative. N. Engl. J. Med. 321, 941-946.
3. Laperche, S., P. Morel, M. Deschaseaux, F. Bouchardeau, G. Alimardani, N. Guillaume, P. Rouger and J. J. Lefrere (2003) HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation. Transfusion 43, 1428-1432.
4. Ohnuma, H., T. Tanaka, A. Yoshikawa, H. Murokawa, K. Minegishi, R. Yamanaka, H. Y. Lizuka, M. Miyamoto, S. Satoh, S. Nakahira, T. Tomono, T. Murozuka, Y. Takada, Y. Doi, H. Mine, S. Yokoyama, T. Hirose and K. Nishiok (2001) The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV. Microbiol. Immunol. 45, 667-672.
5. Pillonel, J. and S. Laperche (2004) Trends in residual risk of transfusion-transmitted viral infections (HTV, HCV, HBV) in France between 1992-2002 and impact of viral genome screening (nucleic acid testing). Transfus. Clin. Biol. 11, 81-86.
6. Bethea, D., B. Fullmer, S. Syed, G. Seltzer, J. Tiano, C. Rischke, L. Gillespie, D. Brown and F. P. Gasparro (1999) Psoralen photobiology and photochemotherapy: 50 years of science and medicine. J. Dermatol. Sci. 19, 78-88.
7. Abe, H. and S. J. Wagner (1995) Analysis of viral DNA, protein and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization. Photochem. Photobiol. 61, 402-408.
8. Atherton, S. I. and A. Harriman (1993) Photochemistry of intercalated methylene blue: photoinduced hydrogen abstraction of guanine and adenine. J. Am. Chem. Soc. 115, 1816-1822.
9. Buchko, G. W., J. Cadet, B. Morin and M. Weinfeld (1995) Photooxidation of d(TpG) by riboflavin and methylene blue. Nucleic Acids Res. 23, 3954-3961.
10. Kasturi, C. (1993) Photochemical Inactivation of Viruses Using Psoralen, Naphthalene and Porphyrin Derivatives: Development of a Protocol for the Selective Inactivation of Viruses in Blood Products. Ph.D. dissertation, The Ohio State University.
11. Kasturi, C. and M. S. Platz (1992) Inactivation of lambda phage with 658 nm light using a DNA binding porphyrin sensitizer. Photochem. Photobiol. 56, 427-429.
12. Ruane, P. H., R. Edrich, D. Gampp, S. D. Keil, R. L. Leonard and R. Goodrich (2004) Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 44, 877-885.
13. Rivlin, R. S. (1970) Riboflavin metabolism. N. Engl. J. Med. 283, 463-472.
14. Heelis, P. F. (1982) The photophysical and photochemical properties of flavins (isoalloxazines). Chem. Soc. Rev. 11, 15-39.
15. Smith, E. C. and D. E. Metzler (1963) The photochemical degradation of riboflavin. J. Am. Chem. Soc. 85, 3285-3288.
16. Jacques, P. F. (1997) Nutritional antioxidants and prevention of age-related eye disease. In Antioxidants and Disease Prevention (Edited by H. S. Garewal) pp. 149-177. CRC Press, Boca Raton, FL.
17. Heelis, P. F. (1991) The photochemistry of flavins. Chem. Biochem. Flavoenzymes 1, 171-193.
18. Broughton, P. M., E. J. Rossitor, C. B. Warren, G. Goules and P. S. Lord (1963) Effect of blue light on hyperbilirubinaemia. Arch. Dis. Child. 40, 666-671.
19. Sisson, T. R. C. (1987) Photodegradation of riboflavin in neonates. Fed. Proc. 46, 1883-1885.
20. Sisson, T. R. C., B. Slaven and P. B. Hamilton (1976) Effect of broad and narrow spectrum fluorescent light on blood constituents. Birth Defects 12, 122-133.
21. Gromisch, D. S., R. Lopez, H. S. Cole and J. M. Cooperman (1977) Light (phototherapy)-induced riboflavin deficiency in the neonate. J. Pediatr. 90, 118-122.
22. Olson, J. H., H. Hertz, S. K. Kjaer, A. Bautz, L. Mellemkjaer and J. D. Boice Jr. (1996) Childhood leukemia following phototherapy for neonatal hyperbilirubinemia (Denmark). Cancer Causes Control 1, 411-414.
23. Gates, F. L. (1930) A study of the bactericidal action of ultraviolet light. III. The absorption of ultraviolet light by bacteria. J. Gen. Physiol. 14, 31-42.
24. Coohill, T. P. (1995) Action spectroscopy: ultraviolet radiation. In CRC Handbook of Organic Photochemistry and Photobiology (Edited by W. M. Horspool), pp. 1257-1266. CRC Press, Boca Raton, FL.
25. Fan, P., A. K. Suri, R. Fiala, D. Live and D. J. Patel (1996) Molecular recognition of the FMN-RNA aptamer complex. J. Mol. Biol. 258, 480-550.
26. Koziol, J. and E. Knobloch (1965) The solvent effect on the fluorescence and light absorption of riboflavin and lumiflavin. Biochim. Biophys. Acta 102, 289-300.
27. -2) as determined by 'NMR shift measurements. Biophys. Chem. 67, 27-34.
28. Szabo, A. G. (2000) Fluorescence principles and measurements. In Spectrophotometry &. Spectrofluorimetry (Edited by M. G. Gore), pp. 33-50. Oxford University Press, Oxford, UK.